Factors to Affect the Provision of Health Data of Users Through PHR App
NCT ID: NCT05036382
Last Updated: 2021-09-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2021-08-25
2021-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Primary Care Usage of Health Promoting Messages
NCT04407962
An Interactive Preventive Health Record (IPHR) to Promote Patient-Centered Preventive Care
NCT00589173
Implementing Personal Health Records to Promote Evidence-Based Cancer Screening
NCT02138448
Effects of the Health Promotion Program on Health Literacy, Physical and Mental Health Status, and Quality of Life
NCT07306520
Electronic Health Records for Health Promotion
NCT00142077
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
(Baseline, 1month) For the first month, researchers send the same data request message to both counties.
1. term, 1 month) The researchers added a message saying, 'Incentives are provided for data sharing' only to the experimental group.
2. term, 1 month) Excludes incentive message for both groups
3. term, 1 month) The researchers added a message saying, 'Incentives are provided for data sharing' only to the control group.
* For equity in both groups, an incentive message was provided to the control group in the last month under the same conditions as the experimental group.
* Only the first 3 months of data were used for the study.
Hypothesis
* In 1-term, the number of data sharing in the experimental group is higher than that in the control group.
* In 1-term, the number of data sharing in the experimental group is more active than baseline period.
* In 2-term, the number of data sharing in the experimental group is still higher than in the baseline period.
* Over the next 1 month, the number of sharing in the experimental group was maintained, which was still higher than that of the control group.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CROSSOVER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental Group
A group that receives an incentive message one month after the start of the experiment
Steps data observation
Sending more step data from the experimental group that received the incentive message
Control Group
A group that does not receive an incentive message (for equity, incentive messages will be sent in the last month of the experiment)
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Steps data observation
Sending more step data from the experimental group that received the incentive message
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* A person who has no difficulty in installing and using PHR app under study
* A person who has expressed his/her willingness to participate voluntarily
Exclusion Criteria
* Those who do not have a smartphone or who are not proficient in using a smartphone
* Persons who are uncooperative and difficult to understand the research method due to cognitive decline
19 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seoul National University Bundang Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seoul National University Bundang Hospital
Gyeonggi-do, Bundang-gu, Seongnam-si, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
clinical trials_1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.